• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在线成本效益分析(OCEAN):一个用于进行宫颈癌成本效益分析的用户友好型界面。

Online Cost-Effectiveness ANalysis (OCEAN): a user-friendly interface to conduct cost-effectiveness analyses for cervical cancer.

机构信息

Barcelona Graduate School of Mathematics (BGSMath), Barcelona, Spain.

Departament de Matemàtiques, Universitat Autònoma de Barcelona (UAB), Cerdanyola del Vallès, 08193, Barcelona, Spain.

出版信息

BMC Med Inform Decis Mak. 2020 Sep 4;20(1):211. doi: 10.1186/s12911-020-01232-9.

DOI:10.1186/s12911-020-01232-9
PMID:32887589
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7487926/
Abstract

BACKGROUND

Most cost-effectiveness analyses in the context of cervical cancer prevention involve the use of mathematical models to simulate HPV infection, cervical disease and prevention strategies. However, it is common for professionals who would need to perform these analyses to not be familiar with the models. This work introduces the Online Cost-Effectiveness ANalysis tool, featuring an easy-to-use web interface providing health professionals, researchers and decision makers involved in cervical cancer prevention programmes with a useful instrument to conduct complex cost-effectiveness analyses, which are becoming an essential tool as an approach for supporting decision-making that involves important trade-offs.

RESULTS

The users can run cost-effectiveness evaluations of cervical cancer prevention strategies without deep knowledge of the underlying mathematical model or any programming language, obtaining the most relevant costs and health outcomes in a user-friendly format. The results provided by the tool are consistent with the existing literature.

CONCLUSIONS

Having such a tool will be an asset to the cervical cancer prevention community, providing researchers with an easy-to-use instrument to conduct cost-effectiveness analyses.

摘要

背景

大多数宫颈癌预防的成本效益分析都涉及使用数学模型来模拟 HPV 感染、宫颈疾病和预防策略。然而,进行这些分析的专业人员通常不熟悉这些模型。本研究引入了在线成本效益分析工具,它具有易于使用的网络界面,为参与宫颈癌预防计划的卫生专业人员、研究人员和决策者提供了一个有用的工具,以进行复杂的成本效益分析,随着需要进行重要权衡的决策支持方法的发展,这些分析正变得越来越重要。

结果

用户无需深入了解底层数学模型或任何编程语言,即可运行宫颈癌预防策略的成本效益评估,以用户友好的格式获得最相关的成本和健康结果。该工具提供的结果与现有文献一致。

结论

拥有这样的工具将是宫颈癌预防界的一项资产,为研究人员提供了一个易于使用的工具来进行成本效益分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f5/7487926/b385f40619f4/12911_2020_1232_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f5/7487926/4e24b52d2cc5/12911_2020_1232_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f5/7487926/21f801feedde/12911_2020_1232_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f5/7487926/b385f40619f4/12911_2020_1232_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f5/7487926/4e24b52d2cc5/12911_2020_1232_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f5/7487926/21f801feedde/12911_2020_1232_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f5/7487926/b385f40619f4/12911_2020_1232_Fig3_HTML.jpg

相似文献

1
Online Cost-Effectiveness ANalysis (OCEAN): a user-friendly interface to conduct cost-effectiveness analyses for cervical cancer.在线成本效益分析(OCEAN):一个用于进行宫颈癌成本效益分析的用户友好型界面。
BMC Med Inform Decis Mak. 2020 Sep 4;20(1):211. doi: 10.1186/s12911-020-01232-9.
2
Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model.智利女性人乳头瘤病毒疫苗的健康经济分析:基于马尔可夫模型的医疗保健支付方视角
BMC Public Health. 2014 Nov 26;14:1222. doi: 10.1186/1471-2458-14-1222.
3
Cervical cancer screening program based on primary DNA-HPV testing in a Brazilian city: a cost-effectiveness study protocol.基于巴西某城市 HPV 初筛的宫颈癌筛查项目:成本效果研究方案
BMC Public Health. 2020 Apr 28;20(1):576. doi: 10.1186/s12889-020-08688-4.
4
Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus.人乳头瘤病毒检测在感染人类免疫缺陷病毒女性中加强宫颈癌筛查的成本效益
Am J Med. 2001 Aug;111(2):140-9. doi: 10.1016/s0002-9343(01)00780-x.
5
Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.中东欧和中亚宫颈癌预防的成本效益。
Vaccine. 2013 Dec 31;31 Suppl 7:H71-9. doi: 10.1016/j.vaccine.2013.04.086.
6
The budget impact of cervical cancer screening using HPV primary screening.采用人乳头瘤病毒(HPV)初筛进行宫颈癌筛查的预算影响
Am J Manag Care. 2016 Mar 1;22(3):e95-105.
7
Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus.接种人乳头瘤病毒疫苗女性的最佳宫颈癌筛查
J Natl Cancer Inst. 2016 Oct 18;109(2). doi: 10.1093/jnci/djw216. Print 2017 Feb.
8
A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program.将人乳头瘤病毒疫苗纳入澳大利亚国家宫颈癌筛查计划的成本效益分析。
Sex Health. 2007 Sep;4(3):165-75. doi: 10.1071/sh07043.
9
The changing landscape for cervical screening.宫颈癌筛查的不断变化态势。
Med J Aust. 2008 Jul 7;189(1):6-7. doi: 10.5694/j.1326-5377.2008.tb01884.x.
10
Cost-effectiveness of cervical cancer prevention.子宫颈癌预防的成本效益
Clin Obstet Gynecol. 2013 Mar;56(1):55-64. doi: 10.1097/GRF.0b013e3182823797.

引用本文的文献

1
Web-based models to inform health policy: A scoping review.用于为卫生政策提供信息的基于网络的模型:一项范围综述。
Health Res Policy Syst. 2025 Aug 4;23(1):99. doi: 10.1186/s12961-025-01367-z.
2
Cost-effectiveness of human papillomavirus (HPV) vaccination in Tunisia: a modelling study.突尼斯人乳头瘤病毒(HPV)疫苗接种的成本效益:一项建模研究。
BMJ Open. 2024 Dec 5;14(12):e085462. doi: 10.1136/bmjopen-2024-085462.

本文引用的文献

1
Impact of model calibration on cost-effectiveness analysis of cervical cancer prevention.模型校准对宫颈癌预防的成本效益分析的影响。
Sci Rep. 2017 Dec 8;7(1):17208. doi: 10.1038/s41598-017-17215-2.
2
Challenges in Cost-Effectiveness Analysis Modelling of HPV Vaccines in Low- and Middle-Income Countries: A Systematic Review and Practice Recommendations.低收入和中等收入国家人乳头瘤病毒疫苗成本效益分析建模面临的挑战:系统评价与实践建议
Pharmacoeconomics. 2017 Jan;35(1):65-82. doi: 10.1007/s40273-016-0451-7.
3
Present and future of cervical cancer prevention in Spain: a cost-effectiveness analysis.
西班牙宫颈癌预防的现状与未来:一项成本效益分析。
Eur J Cancer Prev. 2016 Sep;25(5):430-9. doi: 10.1097/CEJ.0000000000000202.
4
Handling Parameter Uncertainty in Cost-Effectiveness Models Simply and Responsibly.简单且负责地处理成本效益模型中的参数不确定性。
Med Decis Making. 2015 Jul;35(5):567-9. doi: 10.1177/0272989X14567475.
5
The estimated lifetime probability of acquiring human papillomavirus in the United States.在美国感染人乳头瘤病毒的估计终生概率。
Sex Transm Dis. 2014 Nov;41(11):660-4. doi: 10.1097/OLQ.0000000000000193.
6
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.全球癌症发病与死亡:GLOBOCAN 2012 数据源、方法与主要模式。
Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.
7
Protecting the underscreened women in developed countries: the value of HPV test.保护发达国家中筛查不足的女性:HPV检测的价值。
BMC Cancer. 2014 Aug 8;14:574. doi: 10.1186/1471-2407-14-574.
8
Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in Canada.建模加拿大人乳头瘤病毒(HPV)-16/18 AS04 佐剂疫苗和人乳头瘤病毒(HPV)-6/11/16/18 疫苗之间交叉保护数据差异的影响。
BMC Public Health. 2012 Oct 13;12:872. doi: 10.1186/1471-2458-12-872.
9
Until which age should women be vaccinated against HPV infection? Recommendation based on cost-effectiveness analyses.女性应在多大年龄接种 HPV 疫苗以预防感染?基于成本效益分析的建议。
J Infect Dis. 2011 Aug 1;204(3):377-84. doi: 10.1093/infdis/jir281.
10
Calibration methods used in cancer simulation models and suggested reporting guidelines.癌症模拟模型中使用的校准方法及建议的报告指南。
Pharmacoeconomics. 2009;27(7):533-45. doi: 10.2165/11314830-000000000-00000.